NATHBIOGEN

NATH BIO-GENES (INDIA)

Small Cap BSE: 537291 NSE: NATHBIOGEN
₹176.55
-1.25 (-0.7%)
As on 16 August, 2022 | 21:07

Nath Bio-Genes (India) Share Price

Nath Bio-Genes (India) Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Nath Bio-Genes (India) Share Returns

  • Over 1 Month -3.83%
  • Over 3 Month -10.79%
  • Over 6 Month -23.53%
  • Over 1 Year -48.88%

Nath Bio-Genes (India) Key Statistics

P/E Ratio -4.1
PEG Ratio 0
Market Cap Cr 336
Price to Book Ratio 0.6
EPS 12.5
Dividend 2.3
Relative Strength Index 42.84
Money Flow Index 27.58
MACD Signal -1.26
Average True Range 7.98

Nath Bio-Genes (India) Investment Rating

  • Master Rating:
  • Nath Bio Genes India has an operating revenue of Rs. 273.08 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of -23% needs improvement, ROE of -12% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 102 indicates it belongs to a poor industry group of Food-Meat Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Nath Bio-Genes (India) Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 209
  • 27
  • 22
  • 15
  • 215
  • 55
  • Operating Expenses Qtr Cr
  • 175
  • 48
  • 16
  • 10
  • 167
  • 44
  • Operating Profit Qtr Cr
  • 34
  • -21
  • 6
  • 4
  • 48
  • 11
  • Depreciation Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • Interest Qtr Cr
  • 3
  • 2
  • 3
  • 3
  • 3
  • 3
  • Tax Qtr Cr
  • 0
  • 3
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 31
  • -116
  • 3
  • 1
  • 45
  • 7

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
177.
-0.8 (-0.45%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 181.86
  • 50 Day
  • 186.15
  • 100 Day
  • 198.96
  • 200 Day
  • 227.14
  • 20 Day
  • 185.17
  • 50 Day
  • 180.52
  • 100 Day
  • 199.95
  • 200 Day
  • 227.03

Nath Bio-Genes (India) Resistance and Support

PIVOT
₹176.5
Resistance
  • First Resistance
  • 179.75
  • Second Resistance
  • 181.7
  • Third Resistance
  • 184.95
Support
  • First Resistance
  • 174.55
  • Second Resistance
  • 171.3
  • Third Resistance
  • 169.35
  • RSI
  • 42.84
  • MFI
  • 27.58
  • MACD Single Line
  • -1.26
  • MACD
  • -2.27

Nath Bio-Genes (India) Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 62,958
  • 4,886,800
  • 77.62
  • Week
  • 29,363
  • 2,196,609
  • 74.81
  • 1 Month
  • 139,719
  • 12,019,987
  • 86.03
  • 6 Month
  • 64,437
  • 4,682,608
  • 72.67

Nath Bio-Genes (India) Result Highlights

Nath Bio-Genes (India) Synopsis

NSE-Food-Meat Products

Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 278.36 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2022. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
  • Market Cap
  • 336
  • Sales
  • 273
  • Shares in Float
  • 1.12
  • No of funds
  • 12
  • Yield
  • 1.12
  • Book Value
  • 0.62
  • U/D Vol ratio
  • 0.2
  • LTDebt / Equity
  • Alpha
  • -0.28
  • Beta
  • 1.27

Nath Bio-Genes (India)

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 41.07%
  • 41.05%
  • 41.03%
  • Mutual Funds
  • 4.62%
  • 4.85%
  • 7.16%
  • Foreign Portfolio Investors
  • 0.11%
  • 0.07%
  • 0.04%
  • Financial Institutions/ Banks
  • Individual Investors
  • 31.29%
  • 29.86%
  • 25.79%
  • Others
  • 22.91%
  • 24.17%
  • 25.98%

Nath Bio-Genes (India) Management

  • Name
  • Designation
  • Mr. Satish Kagliwal
  • Managing Director
  • Mr. Madhukar Deshpande
  • Director
  • Ms. Ashu Jain
  • Director
  • Mr. Hitesh Purohit
  • Director
  • Mrs. Jeevanlata Kagliwal
  • Director
  • Mr. Vadla Nagabhushanam
  • Director
  • Mrs. Sweta Kagliwal
  • Director

Nath Bio-Genes (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nath Bio-Genes (India) Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-13
  • Quarterly Results
  • 2022-05-30
  • Audited Results, Dividend & A.G.M.
  • 2022-02-11
  • Quarterly Results
  • 2021-11-01
  • Quarterly Results
  • 2021-08-10
  • Quarterly Results

Nath Bio-Genes (India) MF Shareholding

  • Name
  • Amount(cr)
  • Aditya Birla Sun Life Pure Value Fund Growth
  • 3923

Nath Bio-Genes (India) FAQs

What is Share Price of Nath Bio-Genes (India) ?

Nath Bio-Genes (India) share price is ₹176 As on 16 August, 2022 | 20:53

What is the Market Cap of Nath Bio-Genes (India) ?

The Market Cap of Nath Bio-Genes (India) is ₹335.5 Cr As on 16 August, 2022 | 20:53

What is the P/E ratio of Nath Bio-Genes (India) ?

The P/E ratio of Nath Bio-Genes (India) is -4.1 As on 16 August, 2022 | 20:53

What is the PB ratio of Nath Bio-Genes (India) ?

The PB ratio of Nath Bio-Genes (India) is 0.6 As on 16 August, 2022 | 20:53

Q1FY23